Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Return on Assets [ROA] (2011 - 2026)

Updated

Emmaus Life Sciences (EMMA) posted Return on Assets [ROA] of -34.35% for Q2 2026, down 19.57 percentage points from -14.78% a year earlier but up 7.99 percentage points from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Emmaus Life Sciences' Return on Assets [ROA] came in at -33.27%, down 11.31 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -35.55 percentage points (FY2020 to FY2025).
  • In prior years, Emmaus Life Sciences' Return on Assets [ROA] was -21.96% in FY2024 (-13.00 pp), -8.95% in FY2023 (+11.29 pp), -20.25% in FY2022 (+7.18 pp) and -27.43% in FY2021 (-29.71 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -42.35% in Q1 2026 to a high of -9.04% in Q4 2023 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last four quarters, with an average year-over-year change of -11.66 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2023, with a gain of 31.47 percentage points; the weakest was Q2 2022, with a drop of 40.97 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -42.35% (Q1 2026), -35.51% (Q4 2025) and -33.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 8.08%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 4.65%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.45%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.10%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -6.13%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.14%
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -34.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.35%
Mar 31, 2026 -42.35%
Dec 31, 2025 -35.51%
Sep 30, 2025 -33.06%
Jun 30, 2025 -14.78%
Mar 31, 2025 -19.25%
Dec 31, 2024 -25.33%
Sep 30, 2024 -13.12%
Jun 30, 2024 -18.95%
Mar 31, 2024 -14.31%
Dec 31, 2023 -9.04%
Sep 30, 2023 -9.70%
Jun 30, 2023 -10.48%
Mar 31, 2023 -25.80%
Dec 31, 2022 -23.50%
Sep 30, 2022 -40.11%
Jun 30, 2022 -41.95%
Mar 31, 2022 -16.75%
Dec 31, 2021 -27.31%
Sep 30, 2021 -15.16%
API Access

Emmaus Life Sciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEY